-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MTX-652 in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MTX-652 in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MTX-652 in Chronic Kidney Disease (Chronic Renal Failure)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abatacept in Immunoglobulin G4-Related Disease (IgG4-RD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abatacept in Immunoglobulin G4-Related Disease (IgG4-RD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abatacept in Immunoglobulin G4-Related Disease (IgG4-RD) Drug Details: Abatacept...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MTX-071 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MTX-071 in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MTX-071 in Osteoarthritis Pain Drug Details:MTX-071 (Lopain) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MTX-005 in Polyomavirus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MTX-005 in Polyomavirus Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MTX-005 in Polyomavirus InfectionsDrug Details:MTX-005 is under development for the treatment of BK...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tocilizumab in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tocilizumab in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tocilizumab in Multiple Myeloma (Kahler Disease) Drug Details: Tocilizumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tocilizumab in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tocilizumab in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tocilizumab in Diffuse Large B-Cell Lymphoma Drug Details: Tocilizumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tocilizumab in Polymyalgia Rheumatica (PMR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tocilizumab in Polymyalgia Rheumatica (PMR) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tocilizumab in Polymyalgia Rheumatica (PMR) Drug Details: Tocilizumab (Actemra /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tocilizumab in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tocilizumab in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tocilizumab in Metastatic Hepatocellular Carcinoma (HCC) Drug Details: Tocilizumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tocilizumab in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tocilizumab in Follicular Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tocilizumab in Follicular Lymphoma Drug Details: Tocilizumab (Actemra / Roactemra) is...